[A clinical experimental study on the therapeutically effective component of retinal phosphatides (author's transl)].
D000596:Amino Acids / Q000008:administration & dosage / Q000627:therapeutic use; D000818:Animals; D002417:Cattle; D004305:Dose-Response Relationship, Drug; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D007267:Injections; D009206:Myocardium; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000627:therapeutic use; D010714:Phosphatidylethanolamines / Q000008:administration & dosage / Q000627:therapeutic use*; D010743:Phospholipids / Q000008:administration & dosage / Q000627:therapeutic use*; D012160:Retina; D012164:Retinal Diseases / Q000188:drug therapy*; D014020:Tissue Extracts / Q000008:administration & dosage / Q000627:therapeutic use; D014794:Visual Fields / Q000187:drug effects; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use
D000596:Amino Acids; D010713:Phosphatidylcholines; D010714:Phosphatidylethanolamines; D010743:Phospholipids; D014020:Tissue Extracts; D014810:Vitamin E
Eine klinisch-experimentelle Studie über den therapeutisch wirksamen Anteil der Netzhautphosphatide. I. Die Abwandlung des Phosphatidkomplexes